Coinbase
COIN
Tesla
TSLA
Strategy
MSTR
4
Meta Platforms
META
5
Amazon
AMZN
US Stock MarketDetailed Quotes
BMRA Biomerica
- 0.612
- +0.001+0.10%
Trading Mar 11 09:37 ET
11.22MMarket Cap-1.85P/E (TTM)
0.620High0.603Low39.62KVolume0.610Open0.611Pre Close24.13KTurnover0.23%Turnover RatioLossP/E (Static)18.34MShares1.27052wk High2.19P/B10.48MFloat Cap0.24252wk Low--Dividend TTM17.12MShs Float23.390Historical High--Div YieldTTM2.78%Amplitude0.170Historical Low0.609Avg Price1Lot Size
Biomerica Stock Forum
Sign in to post a comment
$Biomerica (BMRA.US)$
Can Biomerica's Newly Certified IBD Tests Transform Crohn's and Colitis Management in Europe?
Can Biomerica's Newly Certified IBD Tests Transform Crohn's and Colitis Management in Europe?
2
$Biomerica (BMRA.US)$ Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn's Disease and Ulcerative Colitis
GlobeNewswire· 2 mins ago
Significant Milestone: Biomerica secures IVDR (In Vitro Diagnostic Regulation) certification, ensuring compliance with stringent European Union standards and allowing sales of the products in the EU
Focus on Precision Medicine: Certification covers Biomerica's food intolerance products developed to support patie...
GlobeNewswire· 2 mins ago
Significant Milestone: Biomerica secures IVDR (In Vitro Diagnostic Regulation) certification, ensuring compliance with stringent European Union standards and allowing sales of the products in the EU
Focus on Precision Medicine: Certification covers Biomerica's food intolerance products developed to support patie...
1
$Biomerica (BMRA.US)$
Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn's Disease and Ulcerative Colitis
Wednesday, 26th February at 8:19 am
• Significant Milestone: Biomerica secures IVDR (In Vitro Diagnostic Regulation) certification, ensuring compliance with stringent European Union standards and allowing sales of the products in the EU
• Focus on Precision Medicine: Certification covers Biomerica's food intolerance products developed...
Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn's Disease and Ulcerative Colitis
Wednesday, 26th February at 8:19 am
• Significant Milestone: Biomerica secures IVDR (In Vitro Diagnostic Regulation) certification, ensuring compliance with stringent European Union standards and allowing sales of the products in the EU
• Focus on Precision Medicine: Certification covers Biomerica's food intolerance products developed...
3
$Biomerica (BMRA.US)$ so great news but it's falling??
1
$Biomerica (BMRA.US)$
Revolutionary IBS Test Achieves 67% Success Rate - Could This End Restrictive Diets?
Revolutionary IBS Test Achieves 67% Success Rate - Could This End Restrictive Diets?
$Biomerica (BMRA.US)$ Reuters
1 min ago
Biomerica’s Infoods® Ibs Clinical Trial Results Published and Featured in Gastroenterology, the Leading Gi Medical Journal
1 min ago
Biomerica’s Infoods® Ibs Clinical Trial Results Published and Featured in Gastroenterology, the Leading Gi Medical Journal
2
$Biomerica (BMRA.US)$ Make BioMERICA great Again...
$Biomerica (BMRA.US)$ did Biomerica have Influenza testkit? If yes, then it is a buy now, 2025 influenza outbreak!
1
2
$Biomerica (BMRA.US)$ I've not seen stock went down so much and then pumped up crazy
$Biomerica (BMRA.US)$ what's happening here
1
No comment yet
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum
Moo Earnings
Jan 24 10:26
TSLA earnings preview: Grab rewards by guessing the opening price!
72241773 : I guess no on care. there is no volume or trading on this. this morning. hoping it changes at the open. I mean it should but this is super low volume for decent news.
MoonGazer 72241773 : Agreed